학술논문

Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial
Document Type
Article
Source
In: The Lancet Gastroenterology and Hepatology. (The Lancet Gastroenterology and Hepatology, September 2023, 8(9):803-815)
Subject
Language
English
ISSN
24681253